June 2020
Volume 61, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2020
Concurrent quantitation of a small molecule sGC stimulator and cGMP in ocular tissue and plasma for target engagement studies after intravitreal administration. Applicability of a matrix-based approach.
Author Affiliations & Notes
  • Pablo Cabral
    Merck & Co., Inc, California, United States
  • Ken Lin
    Merck & Co., Inc, California, United States
  • Sherry Lu
    Merck & Co., Inc, California, United States
  • Joana Galvao
    Merck & Co., Inc, California, United States
  • Suzy El Bader
    Merck & Co., Inc, California, United States
  • Maribel Beaumont
    Merck & Co., Inc, California, United States
  • Santhosh Satapati
    Merck & Co., Inc, California, United States
  • Harish Shankaran
    Merck & Co., Inc, California, United States
  • Paul Rearden
    Merck & Co., Inc, California, United States
  • Marc Bruder
    Merck & Co., Inc, California, United States
  • Alan Whitehead
    Merck & Co., Inc, California, United States
  • John Higgins
    Merck & Co., Inc, California, United States
  • Jason Cox
    Merck & Co., Inc, California, United States
  • Tony Tam
    Merck & Co., Inc, California, United States
  • Antonio Cabal
    Merck & Co., Inc, California, United States
  • Paul E Carrington
    Merck & Co., Inc, California, United States
  • Footnotes
    Commercial Relationships   Pablo Cabral, Merck & Co., Inc (E); Ken Lin, Merck & Co., Inc (E); Sherry Lu, Merck & Co., Inc (E); Joana Galvao, Merck & Co., Inc (E); Suzy El Bader, Merck & Co., Inc (E); Maribel Beaumont, Merck & Co., Inc (E); Santhosh Satapati, Merck & Co., Inc (E); Harish Shankaran, Merck & Co., Inc (E); Paul Rearden, Merck & Co., Inc (E); Marc Bruder, Merck & Co., Inc (E); Alan Whitehead, Merck & Co., Inc (E); John Higgins, Merck & Co., Inc (E); Jason Cox, Merck & Co., Inc (E); Tony Tam, Merck & Co., Inc (E); Antonio Cabal, Merck & Co., Inc (E); Paul Carrington, Merck & Co., Inc (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4623. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pablo Cabral, Ken Lin, Sherry Lu, Joana Galvao, Suzy El Bader, Maribel Beaumont, Santhosh Satapati, Harish Shankaran, Paul Rearden, Marc Bruder, Alan Whitehead, John Higgins, Jason Cox, Tony Tam, Antonio Cabal, Paul E Carrington; Concurrent quantitation of a small molecule sGC stimulator and cGMP in ocular tissue and plasma for target engagement studies after intravitreal administration. Applicability of a matrix-based approach.. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4623.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Soluble guanylate cyclase (sGC) and its endogenous ligand Nitric Oxide (NO) are expressed throughout ocular tissue. NO activates sGC leading to the production of the second messenger cyclic guanosine monophosphate (cGMP), which in turns triggers downstream cGMP-dependent signaling pathways. The NO-sGC pathway is involved in intraocular pressure regulation. We developed an assay to provide pharmacokinetic and target engagement data for intravitreal administration of a soluble guanylate cyclase stimulator.

Methods : A liquid chromatography tandem mass spectrometry assay was qualified for the concurrent measurement of a small molecule sGC stimulator and its target engagement biomarker, cGMP, in ocular tissues and plasma. A surrogate matrix approach was used in this assay due to limited quantities of blank ocular matrices in a preclinical discovery research setting. The need for a surrogate matrix is further compounded by endogenous levels of biomarker.

Results : We demonstrated appropriate parallelism between the surrogate matrix and the authentic animal matrices (rabbit plasma, vitreous, and retina-choroid). After assay optimization was completed, qualification experiments showed high accuracy, precision, recovery, and stability.

Conclusions : Dose dependent exposure of the sGC stimulator was found in rabbit vitreous, retina-choroid, and plasma. We detected increased levels of cGMP in vitreous humor, but not retina-choroid. Concurrent measurements of both pharmacokinetic and pharmacodynamic analytes resulted in higher throughput data generation and provided improved context for interpreting PK and PD relationships.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×